GURUFOCUS.COM » STOCK LIST » Technology » Software » Core Scientific Inc (OTCPK:CORZQ) » Definitions » ROE %

Core Scientific (Core Scientific) ROE % : Negative Equity% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Core Scientific ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Core Scientific's annualized net income for the quarter that ended in Mar. 2024 was $842.8 Mil. Core Scientific's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was $-457.7 Mil. Therefore, Core Scientific's annualized ROE % for the quarter that ended in Mar. 2024 was Negative Equity%.

The historical rank and industry rank for Core Scientific's ROE % or its related term are showing as below:

During the past 5 years, Core Scientific's highest ROE % was 6.62%. The lowest was -460.65%. And the median was -11.85%.

CORZQ's ROE % is not ranked *
in the Software industry.
Industry Median: 3.22
* Ranked among companies with meaningful ROE % only.

Core Scientific ROE % Historical Data

The historical data trend for Core Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Scientific ROE % Chart

Core Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
-11.21 -12.48 6.62 -460.65 -

Core Scientific Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - Negative Equity

Competitive Comparison of Core Scientific's ROE %

For the Software - Infrastructure subindustry, Core Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Scientific's ROE % Distribution in the Software Industry

For the Software industry and Technology sector, Core Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Core Scientific's ROE % falls into.



Core Scientific ROE % Calculation

Core Scientific's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-246.487/( (-409.346+-596.941)/ 2 )
=-246.487/-503.1435
=N/A %

Core Scientific's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=842.764/( (-596.941+-318.509)/ 2 )
=842.764/-457.725
=Negative Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Core Scientific  (OTCPK:CORZQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=842.764/-457.725
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(842.764 / 717.164)*(717.164 / 763.062)*(763.062 / -457.725)
=Net Margin %*Asset Turnover*Equity Multiplier
=117.51 %*0.9399*N/A
=ROA %*Equity Multiplier
=110.45 %*N/A
=Negative Equity %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=842.764/-457.725
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (842.764 / 843.588) * (843.588 / 242.888) * (242.888 / 717.164) * (717.164 / 763.062) * (763.062 / -457.725)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.999 * 3.4732 * 33.87 % * 0.9399 * N/A
=Negative Equity %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Core Scientific ROE % Related Terms

Thank you for viewing the detailed overview of Core Scientific's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Scientific (Core Scientific) Business Description

Traded in Other Exchanges
Address
210 Barton Springs Road, Austin, TX, USA, 78704
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
Executives
Adam Taylor Sullivan officer: President C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704
Darin Feinstein director, 10 percent owner, officer: Chief Vision Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Sterling Denise Marie Brucia officer: Chief Financial Officer C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704
Matt Minnis director 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Brian Neville officer: Chief Accounting Officer C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004
Todd M Duchene officer: EVP, GC and Secretary 847 GIBRALTAR DR., MILPITAS CA 95035
Michael Trzupek officer: Chief Financial Officer 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004
Stacie Olivares director 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016
Jarvis V. Hollingsworth director 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205
Michael J Levitt director, officer: Chief Executive Officer KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067
Dr Kneeland Youngblood director C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105
John P Mcgarrity officer: General Counsel and Secretary 321 N. CLARK STREET, CHICAGO IL 60054
Sullivan Colleen director 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037
Theodore J Brombach 10 percent owner 321 N. CLARK STREET, CHICAGO IL 60054
Patrick C Eilers director, 10 percent owner, officer: Chief Executive Officer THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602

Core Scientific (Core Scientific) Headlines

From GuruFocus